REVB Revelation Biosciences Inc
Price (delayed)
$2.92
Market cap
$2.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$87.68
Enterprise value
-$3.86M
Highlights
The quick ratio has soared by 111% since the previous quarter and by 58% year-on-year
The EPS has surged by 71% since the previous quarter
REVB's equity has surged by 76% since the previous quarter but it is down by 29% year-on-year
Key stats
What are the main financial stats of REVB
Market
Valuations
Earnings
Shares outstanding
905,228
Market cap
$2.64M
Enterprise value
-$3.86M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.17
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$7.98M
Net income
-$15.04M
EBIT
-$15.04M
EBITDA
-$15.01M
Free cash flow
-$18.34M
Per share
Balance sheet
Liquidity
EPS
-$87.68
EPS diluted
-$87.68
Free cash flow per share
-$106.94
Book value per share
$17.55
Revenue per share
$0
TBVPS
$38.61
Total assets
$6.62M
Total liabilities
$1.91M
Debt
$0
Equity
$4.71M
Working capital
$4.65M
Debt to equity
0
Current ratio
3.43
Quick ratio
3.4
Net debt/EBITDA
0.43
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-149.1%
Return on equity
-334.3%
Return on invested capital
N/A
Return on capital employed
-319.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
REVB stock price
How has the Revelation Biosciences stock price performed over time
Intraday
-0.34%
1 week
-5.19%
1 month
1.39%
1 year
-91.47%
YTD
-60.43%
QTD
11.03%
Financial performance
How have Revelation Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.98M
Net income
-$15.04M
Gross margin
N/A
Net margin
N/A
REVB's operating income is up by 8% YoY and by 7% from the previous quarter
The net income is up by 3.1% QoQ
Growth
What is Revelation Biosciences's growth rate over time
Valuation
What is Revelation Biosciences stock price valuation
P/E
N/A
P/B
0.17
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 71% since the previous quarter
The price to book (P/B) is 83% lower than the last 4 quarters average of 1.0
REVB's equity has surged by 76% since the previous quarter but it is down by 29% year-on-year
Efficiency
How efficient is Revelation Biosciences business performance
The company's return on assets fell by 10% QoQ
REVB's return on equity is down by 7% since the previous quarter
Dividends
What is REVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for REVB.
Financial health
How did Revelation Biosciences financials performed over time
The quick ratio has soared by 111% since the previous quarter and by 58% year-on-year
The company's current ratio has surged by 109% QoQ and by 57% YoY
The debt is 100% less than the equity
REVB's equity has surged by 76% since the previous quarter but it is down by 29% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.